| Serial Number | 90382648 |
| Word Mark | SANGENTRI |
| Filing Date | Tuesday, December 15, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 13, 2021 |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 23, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Friday, December 18, 2020 | NEW APPLICATION ENTERED |
| Tuesday, February 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, May 29, 2021 | ASSIGNED TO EXAMINER |
| Monday, May 31, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, May 31, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, May 31, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 3, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 3, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 3, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 4, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 23, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 13, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 13, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 11, 2021 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, September 22, 2021 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, November 2, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 1, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 27, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 27, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, April 27, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, April 29, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 1, 2022 | SOU EXTENSION 2 FILED |
| Tuesday, November 1, 2022 | SOU EXTENSION 2 GRANTED |
| Friday, October 27, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 27, 2023 | SOU EXTENSION 4 FILED |
| Friday, October 27, 2023 | SOU EXTENSION 4 GRANTED |
| Monday, June 3, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, July 12, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Tuesday, October 31, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 3, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 18, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 18, 2023 | SOU EXTENSION 3 FILED |
| Tuesday, April 18, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, April 20, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |